{"id":53483,"name":"MEMSEL, INC.","slug":"memsel-inc","state":"TX","country":"United States of America","description":"Scientific research & development company","totalSpending":250000,"filings":14,"yearlySpending":[{"year":2022,"income":20000},{"year":2023,"income":90000},{"year":2024,"income":70000},{"year":2025,"income":70000}],"issues":[{"code":"DEF","display":"Defense"},{"code":"HCR","display":"Health Issues"},{"code":"BUD","display":"Budget/Appropriations"}],"firms":["VAN SCOYOC ASSOCIATES"],"lobbyists":["MICHAEL SHUPP","LAUREN BRESETTE","JENNIFER CAVE","MADHUMITHA THYAGARAJAN"],"govEntities":["Defense, Dept of (DOD)","Army, Dept of (Other)","HOUSE OF REPRESENTATIVES","Office of the Secretary of Defense","SENATE"],"sampleDescriptions":["Advanced Wound Management Technology","Advanced Wound Management Technology","Development of Advanced Wound Healing Systems","Development of Advanced Wound Healing Systems","Advanced Wound Healing System and Phage Therapeutics, as follows: Department of Defense Appropriations Act,FY2024 National Defense Authorization Act for Fiscal Year 2024"]}